Actionable companion · Assessment and evidence of learning
From evidence to district action: Pharmacy Students’ Perspectives on Integrating Generative AI into Pharmacy Education
AI-assisted editorial implementation guide. The district actions are proposed applications, not findings or recommendations attributed to the original authors. No additional peer review is asserted.
Evidence and context
Confirm the study population, setting and task before applying its findings to your district.
Original authors’ abstract, reproduced under the linked source license:
Abstract Objective: This study aims to evaluate pharmacy students’ perceptions regarding the integration of generative artificial intelligence (GenAI) into pharmacy curricula, providing evidence to inform future curriculum development. Methods: A cross-sectional survey of Doctor of Pharmacy (PharmD) students at a single U.S. College of Pharmacy was conducted in April 2025. Students from all four professional years (P1–P4) were invited to participate. The 10-item survey assessed four domains: (1) General GenAI Use, (2) Knowledge and Experience with GenAI Tools, (3) Learning Preferences with GenAI, and (4) Perspectives on GenAI in the curriculum. Results: A total of 110 students responded (response rate = 12.4%). Most were P1 students (56/110, 50.9%). Many reported using GenAI tools for personal (65/110, 59.1%) and school-related purposes (64/110, 58.1%) sometimes, often, or frequently. ChatGPT was the most used tool. While 40% (40/99) agreed or strongly agreed that GenAI could enhance their learning, 62.6% (62/99) preferred traditional teaching methods. Open-ended responses (n = 25) reflected a mix of positive, neutral, and negative views on GenAI in education. Conclusions: Many pharmacy students in this cohort reported using GenAI tools and demonstrated a basic understanding of GenAI functions, yet students also reported that they preferred traditional learning methods and expressed mixed views on incorporating GenAI into teaching. These findings provide valuable insights for faculty and schools of pharmacy as they develop strategies to integrate GenAI into pharmacy education. Keywords: artificial intelligence, pharmacy education, pharmacy, pharmacy student
A 90-day district pilot
- Days 1–15 · Appraise. Have the curriculum lead and a teacher read the methods and limitations. Record the study design, sample, comparator, outcomes and evidence gaps. Define a local question that the study can help inform.
- Days 16–30 · Design. Redesign one low-stakes assessment: require a first attempt, an AI-assisted revision, a source-check log and a short oral explanation. Use the same rubric for the comparison task. Name an accountable owner and set the baseline, success threshold and budget before implementation.
- Days 31–60 · Test. Start with a small voluntary cohort, preserve an accessible non-AI route and require teacher review. Use synthetic or de-identified examples; approve data handling and tool terms through district processes.
- Days 61–90 · Decide. Blind-score reasoning, factual accuracy and unaided transfer on a fresh task. Record suspected misconduct separately from demonstrated evidence. Compare with baseline, document uncertainty and stop or revise if learning worsens, access is unequal or critical errors persist.
The board decision brief
Report the learning problem, evidence quality, participating population, total cost including review time, measured benefit, errors, access differences and remaining uncertainties. Make a dated recommendation to stop, revise or expand. A positive perception survey alone does not establish learning improvement.
Attribution and reuse
Kaitlin M Alexander; Eli O Jorgensen; Casey Rowe; Khoa Nguyen. Pharmacy Students’ Perspectives on Integrating Generative AI into Pharmacy Education. Pharmacy (2025-12-15). https://doi.org/10.3390/pharmacy13060183
Companion prepared 2026-10-30. Original authorship and DOI are preserved. The abstract is an attributed source extract; the implementation plan is new AI-assisted editorial material, offered under the same CC BY 4.0 license. This guide has not undergone independent peer review.